SCHEMBL5329025

SCHEMBL5329025

CC(C)Cn1sc(-c2ccccc2)c(NCC(O)CO)c1=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.35
KAT2A Q92830 2/20 0.33
KAT2B Q92831 2/20 0.33
CCNE2 O96020 1/20 0.33
CCNE1 P24864 1/20 0.33
CDK2 P24941 1/20 0.33
CHEK1 O14757 1/20 0.33
CDK1 P06493 1/20 0.33
ALDH1A1 P00352 1/20 0.33
DPP4 P27487 3/20 0.32
PRKDC P78527 1/20 0.32
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ABCB1 P08183 2/20 0.31
EGFR P00533 1/20 0.31
SRC P12931 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3653144 0.80 SMN1; SMN2 (0.36) SMN1; SMN2CCNE2CCNE1CDK2CHEK1
SCHEMBL17844070 0.68 FAAH (0.40) KAT2BALDH1A1TSHRTDP1L3MBTL1
SCHEMBL17844132 0.60 FAAH (0.39) KAT2AKAT2BALDH1A1HSD17B10
SCHEMBL1298434 0.60 MAPT (0.61) SMN1; SMN2ALDH1A1
SCHEMBL1123439 0.59 CASP3 (0.67) KAT2AKAT2B
SCHEMBL29679134 0.59 CASP3 (0.67) KAT2AKAT2B
SCHEMBL3399719 0.58 POLB (0.60) ALDH1A1
SCHEMBL3399725 0.58 POLB (0.60) ALDH1A1
SCHEMBL16005719 0.57 IDH1 (0.49) CCNE2CCNE1CDK2CHEK1CDK1
SCHEMBL17844088 0.57 KDM4E (0.40) SMN1; SMN2ALDH1A1TSHRHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838687-A1 NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2007-10-03 EP disclosed
WO-2006073366-A1 NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2006-07-13 WO disclosed